Published Date: 12 Jul 2023
A systematic study called the Global Burden of Disease (GBD) compares the magnitude of health losses caused by various diseases and injuries globally. In order to quantify the health damage caused, disability weights are essential.
Read Full NewsThree imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.
Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.
Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.
Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.
U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a focus on...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.
1.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
2.
Improved end-of-life conversations for cancer patients are identified by a new study.
3.
The most precise research tools for the deadliest blood cancer have been developed.
4.
Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant
5.
Researchers find distinct cell receptors with the potential for new treatments.
1.
Exploring the Latest Treatments for Essential Thrombocythemia
2.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
3.
Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis
4.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
5.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation